Back to search

Article

Computational Approaches to Identification and Characterization of Masitinib as Potential Treatment for Alzheimer's Disease through Molecular Docking and Two-sample Mendelian Randomization

2024-11-08

Abstract excerpt

<title>Abstract</title> <p>Background Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by declines in cognitive and functional abilities. Masitinib has demonstrated potential in AD clinical trials, but its precise mechanism of action in the context of AD remains unclear. Advancing computational techniques is one approach to identifying novel and repurposable agents that may be t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7acc4c1e-ede1-5580-b318-a7cb79c6138f
DOI
10.21203/rs.3.rs-5339703/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Computational Approaches to Identification and Characterization of Masitinib as Potential Treatment for Alzheimer's Disease through Molecular Docking and Two-sample Mendelian RandomizationDOI 10.21203/rs.3.rs-5339703/v1
Mendelian Randomization Identified CHRNE as a Potential Drug Target for Alzheimer’s diseaseSemantic proximity
Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s diseaseSemantic proximity
VEGFB is a potential therapeutic target for Alzheimer's disease: Insights from integrative multi-omics analysis.Semantic proximity
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer’s disease risk: a pQTL-based Mendelian randomization and colocalization analysisSemantic proximity
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.Semantic proximity
Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African AmericansSemantic proximity
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomization studySemantic proximity
Causality between Alzheimer disease and delirium: A two-sample Mendelian randomization study and gene colocalization analyses.Semantic proximity
Associations of Alzheimer’s disease with inpatient hospital costs and with quality-adjusted life years: Evidence from conventional and Mendelian randomization analyses in the UK BiobankSemantic proximity
Targeting Fyn kinase for alleviation of cognitive impairment in Streptozocin-induced Alzheimer’s disease in mice by Loperamide; An Experimental and In silico analysisSemantic proximity
Select a neighboring publication to make it the new centre.